Industry News
Related Searches:
Filter by:
1921 - 1935 of 2387 results
July 13, 2007
Pharming Group's facilities for the manufacture of Rhucin have passed all EMEA inspections, establishing GMP compliance for pharmaceutical production. The EMEA has confirmed that all facilities and processes involved in the manufacture of Rhucin, Pha…
Read More »
July 13, 2007
DSM and Crucell entered a non-exclusive PER.C6 research licensing agreement with Russia-based Masterclone. Masterclone will use Crucell’s technology to develop an undisclosed antibody. Financial details were not disclosed.
The PER.C6 techn…
Read More »
July 12, 2007
Icon has acquired DOCS International, a European clinical research staffing organization, for approximately $40 million in cash. DOCS operates in eight countries and focuses on the training and supply of contract and permanent clinical research perso…
Read More »
July 12, 2007
QSV Biologics and Alseres Pharmaceuticals have signed a contract for the process development and cGMP manufacture of Cethrin for spinal cord injury. QSV will be responsible for technology transfer, process development and cGMP manufacture of Phase II…
Read More »
July 11, 2007
Azopharma has reached an agreement to purchase Kos Pharmaceuticals' R&D facility along with assets in Hollywood, FL. Azopharma chief executive officer Phil Meeks said, "We are pleased about the addition of our new facility in Hollywood, FL,…
Read More »
July 10, 2007
Noven Pharmaceuticals, Inc. has agreed to acquire JDS Pharmaceuticals, LLC for approximately $125 million in cash and take on approximately $10 million in liabilities. JDS is a privately-held specialty pharmaceutical company that currently markets tw…
Read More »
July 9, 2007
Novavax, Inc. signed a non-exclusive, worldwide license agreement with Wyeth for the rights to a patent application covering virus-like particle (VLP) technology for vaccines. The agreement includes an upfront payment, annual license fees, milestone…
Read More »
July 9, 2007
InterMune, Inc. has entered into a new supply agreement with Boehringer Ingelheim Austria GmbH for Actimmune, eliminating InterMune's $91.6 million in future purchase commitments that existed under the previous supply agreement. InterMune will pay BI…
Read More »
July 6, 2007
Quintiles Transnational Corp. has announced plans to expand and consolidate its Global Central Laboratories (GCL) in Smyrna, GA, and its Clinical Development Services (CDS) office in Atlanta within a single structure in nearby Marietta, GA.
The 20…
Read More »
July 5, 2007
DSM subsidiary DSM Nutritional Products Ltd. has acquired privately owned Pentapharm Holding Ltd. Pentapharm is a developer and producer of active ingredients and system solutions for the cosmetics industry but also has a presence in pharmaceutical a…
Read More »
July 3, 2007
Novartis Vaccines will increase the supply of its Fluvirin vaccine 30% for distribution in the U.S. during the 2007-2008 flu season and plans to produce approximately 40 million doses. Based on accelerated production plans, half of these doses are pl…
Read More »
July 2, 2007
Abraxis BioScience, Inc. has plans to split its hospital-based product business, Abraxis Pharmaceutical Products (APP) and Abraxis Oncology and Abraxis Research (the new Abraxis BioScience), into two independent, public companies. According to the co…
Read More »
June 29, 2007
PharmaNet Development Group, Inc. has opened a new Phase I clinic in Toronto, Canada and new offices in Brussels, Belgium and Milan, Italy. The company has also relocated its Zurich, Switzerland office to allow for future growth of its staff.
&q…
Read More »
June 28, 2007
SGS India Ltd.'s Chennai facility has passed an FDA inspection conducted in February 2007. It was both a pre-approval and a GMP inspection. The facility is classified as "acceptable." This was the first FDA inspection of the SGS QC testing…
Read More »
June 25, 2007
Roche and Toyama Chemical Co. have entered into a licensing agreement for the research, development and commercialization of Toyama's oral rheumatoid arthritis agent T-5224. By inhibiting a specific inflammatory process, T-5224 has the potential to b…
Read More »
1921 - 1935 of 2387 results
